Abstract
Sympathetic stimulation modulates L-type calcium channel (LTCC) gating to contribute to increased systolic heart function. Rad is a monomeric G-protein that interacts with LTCC. Genetic deletion of Rad (Rad−/−) renders LTCC in a sympathomimetic state. The study goal was to use a clinically inspired pharmacological stress echocardiography test, including analysis of global strain, to determine whether Rad−/− confers tonic positive inotropic heart function. Sarcomere dynamics and strain showed partial parallel isoproterenol (ISO) responsiveness for wild-type (WT) and for Rad−/−. Rad−/− basal inotropy was elevated compared to WT but was less responsiveness to ISO. Rad protein levels were lower in human patients with end-stage non-ischemic heart failure. These results show that Rad reduction provides a stable inotropic response rooted in sarcomere level function. Thus, reduced Rad levels in heart failure patients may be a compensatory response to need for increased output in the setting of HF. Rad deletion suggests a future therapeutic direction for inotropic support.
Keywords: Calcium channel, Echocardiography, Calcium, Cell shortening, Beta-adrenergic stimulation, Heart function
Introduction
The heart undergoes extensive remodeling during progression from healthy to failing. Pathological features include hypertrophy of cardiac myocytes and excessive deposition of extracellular matrix. At late stages of remodeling, cardiomyocyte hypertrophy is associated with loss of inotropic function. In addition, the failing heart displays non-responsiveness to β-adrenergic receptor (β-AR) agonists. Cardiac fibrosis contributes to arrhythmias and systolic and diastolic dysfunction [1]. Initial responses to pathological stimuli may illuminate compensatory pathways that can be targeted to preserve normal heart function. Limited studies suggested that the protein Rad may decline in human heart failure patients [2], and in mice, decreased Rad levels constitute part of an early response to pressure overload hypertrophy [2]. Genetic deletion of Rad in the mouse (Rad−/−) leads to a stable compensatory remodeled heart with improved systolic function [3].
The Rad knockout mouse model presents a unique opportunity to dissect contributions of cellular hypertrophic remodeling, myocardial Ca2+ handling, and fibrosis to cardiac function. Rad is a monomeric Ras-related protein expressed in the myocardium [2, 4, 5]. Rad interacts with the L-type Ca2+ channel complex (LTCC) [6] and governs LTCC activity [3, 4, 7]. The Rad−/− heart presents a complex cell/molecular phenotype. Deletion of Rad increases LTCC activity [4], and this increased current along with increased SERCA2a expression lead to increases in SR Ca2+ load [3]. At the cellular and ex vivo working heart levels, Rad deletion leads to a sympathomimetic positive inotropic contractile state [4]. Rad−/− cardiomyocytes are hypertrophied, and the Rad−/− myocardium displays increased fibrosis [3, 8]. Rad−/− hearts showed no evidence of arrhythmogenesis [4], and Rad deletion preserves systolic heart function well into senescence [3]. Taken together, these findings suggest that decreased Rad levels impart stable compensatory inotropic function in response to increased preload and afterload in the failing heart.
Echocardiography is a proven tool for non-invasively assessing heart function in vivo. LV ejection fraction (EF) reduction reflects global LV systolic dysfunction. EF is known to occur late after disease onset, is not an early indicator, and is a prognostic indicator. Speckle-tracking image analysis allows for more sensitive and accurate assessment of function. In animal models, abnormal strain is an early indicator of pathology that precedes fibrosis and systolic dysfunction [9, 10].
We were motivated to further evaluate Rad−/− myocardial function beyond ejection fraction and wall dimensions. Initial studies associated Rad deletion with dysfunction [2, 8, 11], and by association, a study on aging inferred that increases of Rad preserve heart function during senescence [12]. By contrast, our recent studies suggest that Rad deletion preserves function during aging. In this study, we used speckle-tracking-based global strain to test the hypothesis that Rad deletion is beneficial for the heart. We incorporated an acute isoproterenol (ISO) stress test that supports preservation of aspects of non-failing βAR signaling in Rad−/− hearts.
Materials and Methods
Animals
Global RRAD null male mice (Rad−/−) were generated as previously described [4]. Age-matched in-house bred C57/Bl6 mice (wild-type, WT) served as controls. Male adult mice (3–4 months) and aged mice (>18 months) were evaluated. The experimental procedures and methods used were approved by the Animal Care and Use Committee of the University of Kentucky, and conformed to the NIH Guide for Care and Use of Laboratory Animals.
Ventricular Myocyte Isolation
Adult ventricular myocyte isolation was performed as in previous studies [4]. Prior to heart excision, mice were anesthetized with ketamine + xylazine (90 + 10 mg/kg intraperitoneal). The hearts were excised from adult Rad−/− and wild type mice and immediately perfused on a Langendorff apparatus with a high-potassium Tyrode buffer and then digested with 5 to 7 mg liberase (Roche). After digestion, the atria were removed and ventricular myocytes were mechanically dispersed. Calcium concentrations were gradually restored to physiological levels in a stepwise fashion, and only healthy quiescent ventricular myocytes were used for electrophysiological analysis or calcium imaging within 12 h.
For simultaneous measurement of cytosolic calcium and sarcomere length, isolated ventricular myocytes were loaded with cell permeable Fura-2 AM at room temperature for 5 min, washed, and re-suspended in physiological saline solution (PSS) containing 1.8 mM calcium. Myocytes were then field stimulated at 1 Hz, and the F340/380 ratio was measured as an indicator of changes in cytosolic calcium concentration. For ISO measurements, cells were paced for 2 min prior to recording in PSS containing 100 nM isoproterenol. Optical imaging of sarcomere frequency was analyzed and converted into sarcomere length using Ion Wizard software (IonOptix, Westwood, MA).
Echocardiography
Transthoracic echocardiography was performed using the Visual Sonics 770 imaging system (Toronto, Canada) equipped with 30-MHz probe. Mice underwent transthoracic echocardiography, under light anesthesia (inhaled isoflurane 1–2%), with heart rate (350–500 beats per minute) and core temperature (37 °C) continuously monitored. The heart was visualized in 2D from modified parasternal long axis, short axis, and apical views. The left ventricular dimensions and calculated left ventricular EF were measured from the short axis M-mode display. Left ventricular systolic strain was derived from the Visual Sonics software-utilizing speckle tracking of the modified parasternal long axis and short axis images. All measurements were obtained in triplicate and averaged. The sonographer was blinded to animal genotype, and data analysis was performed with animal genotype blinded.
For the pharmacological stress test, a single I.P. injection of isoproterenol (ISO, 30 mg/kg, USP) was given immediately after baseline echocardiography measures were recorded. Heart rate was monitored; within 5 min, a heart rate increase; confirmed drug effect and echocardiography measures were repeated (marked ISO in graphs).
Human Heart: Patient Tissue
De-identified human heart lysates from individuals without heart failure and with end-stage non-ischemic dilated cardiomyopathy were obtained from the Cedars-Sinai Heart Institute Biobank. Heart failure tissue was obtained from the hearts removed at the time of transplant, and non-failing tissue was obtained from previously healthy organ donors whose hearts were not transplanted for technical reasons. For each heart, cold cardioplegia was perfused antegrade prior to cardiectomy, and the explanted heart was placed immediately in ice-cold physiologic solution. Full-thickness samples from the free wall of the left ventricle were cleaned rapidly of all epicardial fat, and aliquoted into cryovials, which were submerged in liquid N2 to snap-freeze before storage at −80 °C.
Western Blotting
For protein lysate preparation, 100 mg of ventricular tissues were homogenized in 1 ml RIPA buffer, followed by sonication and centrifugation at 10,000 g for 20 min at 4 °C. Protein concentration in the clarified lysates was determined using the BioRad DC Protein Assay and normalized. Human heart homogenates were diluted in SDS sample buffer and loaded into a 10% Criterion Tris–HCl StainFree gel (BioRad) at 30 μg per lane. Individual heart lysates were normalized to total protein (Fig. 1c) as measured with Image Lab software (BioRad) prior to transfer onto Protran nitrocellulose membrane (Amersham). The membrane was blocked in TBS with 5% dry milk and 0.1% Tween20 before incubation with goat anti-Rad primary antibody (Everest Biosciences EB11418, 1:1000). Following washes and incubation with HRP-conjugated rabbit anti-goat secondary antibody (Jackson Immunochemicals), the blot was developed with SuperSignal West Pico (Thermo Scientific) and visualized on a ChemiDoc MP (BioRad). Image Lab was used to quantify band intensities, and the data were analyzed by t test in GraphPad Prism.
Run to Exhaustion, Exercise Tolerance Test
Mice ran on a 6-lane powered treadmill (Exer3/6, Columbus Instruments, Columbus, OH) using a protocol modeled from reference [13]. A two-day acclimatization period consisted of 5 m/min for 5 min on day 1. The day 2 protocol was a 3-min stationary period, followed by 5 m/min for 5 min with speed gradually increased to 21 m/min for an additional 15 min. If mice stopped running, they were gently patted on the hindquarters. Mice that refused to run during day 2 were excluded from analysis. For the exercise tolerance test on day 3, mice were run until they reached volitional exhaustion. Treadmill speed was gradually increased to 21 m/min; this pace was maintained until exhaustion. Exhaustion was defined as failure to keep up with treadmill despite hindquarter prods. Time to exhaustion was recorded and plotted. Investigators were blinded to mouse genotype.
Statistics
Data are presented as mean ± standard error of the mean. Tests for effects of genotype and aging were made on independent groups and evaluated with one-way analysis of variance (ANOVA) and post-hoc Tukey tests. For ISO stress test measurements, the difference of ISO and baseline for each sample was evaluated for t tests for a difference = 0. Additionally, a two-way ANOVA was applied to data to analyze interactions, ISO, and genotype effects. p < 0.05 was considered statistically significant. We used GraphPad Prism v6.0 (San Diego, Ca).
Results
Rad−/− Hearts Exhibit Canonical Hypertrophic Remodeling Markers but Maintain Preserved Systolic and Diastolic Function in Aging
The Rad−/− mouse heart presents with increased fibrosis [3, 8] and thicker ventricular walls, but preserved E/A ratio [3]. These contradictory findings motivated us to perform a more in-depth examination of the Rad−/− heart. Strain is an early indicator of LV systolic dysfunction. We therefore used speckle-tracking echocardiography to evaluate global and regional strain in WT and Rad−/− in adult and aged mice (Fig. 1a). Global longitudinal strain was not significantly different in adult. With aging, there was a significant decline in WT, but not in Rad−/− (Fig. 1b). Global circumferential strain showed more discrete changes between WT and Rad−/−. Adult global circumferential strain was significantly greater in Rad−/− compared to WT in adult and aged mice (Fig. 1c).
Figure 2a shows heart orientation juxtaposed to a schematic for evaluating regional strain. Regional longitudinal strain was not different between WT and Rad−/− in adult or with aging except for the basal inferior-lateral region (Fig. 2b). By contrast, for all regions of circumferential strain, mean values were greater in Rad−/− than in WT in adult and aging (Fig. 2c). Three regions, the anterior-lateral, inferior-lateral, and anterior-septal regions, reached statistical significance (Fig. 2c). With aging, the spread between mean values reduced suggesting that Rad−/− heart function was maintained but susceptible to aginginduced decline of function. The important point is that despite increased fibrosis and remodeled LV, Rad deletion preserves many detectable aspects of LV function in adult.
ISO Response In Vivo
We performed an ISO stress test paradigm for echocardiography inspired by the clinical stress test (for patients unable to exercise) to reveal deficits in function triggered by heart remodeling. Adult mice were imaged at baseline and acutely administered ISO. Within 5 min, HR was elevated and the hearts were re-imaged. Ejection fraction was significantly increased by ISO in WT (59.5 ± 0.6% at baseline; 92.8 ± 1.7% ISO; Fig. 3a). The ISO effect on EF was greater for WT than that for Rad−/− (mean difference 33.3 ± 1.8 versus 7.4 ± 1.1%, for WT and Rad−/−, respectively; Fig. 3b). EF plotted as a function of HR showed a weak relationship, but linear regression analysis did not indicate a slope significantly different from zero (Fig. 3c). Thus, EF increases are independent of HR over the range of HR measured. Maximal LV diastolic chamber dimensions (LVID;d) tracked with changes in EF for WT (Fig. 3d). HR did not contribute to ISO-induced decrease of LVID;d (Fig. 3e). The ISO effect to decrease LVID;d was significant for WT but not for Rad−/− (Fig. 3f).
Global longitudinal and circumferential strain were significantly enhanced by ISO for WT, but not for Rad−/− (Fig. 4a–d). Strain is expressed as percent change and therefore can be influenced by changes in chamber dimensions whereby smaller LVID;d results in apparent enhanced strain, all else being equal. Plots of longitudinal and circumferential strain as a function of LVID;d demonstrate that this relationship holds for WT under basal conditions and for Rad−/− for basal and acute ISO (Fig. 4e, f). Regional strain showed non-uniform responses to ISO. Longitudinal regional strain was not affected by Rad deletion but was significantly enhanced by ISO in the posterior base, posterior midwall, anterior midwall, and anterior apical segments (Table 1). The mean circumferential strain for each segment was greater than that for Rad than WT (Table 2). Analysis by segment showed an interaction effect for the lateral region and ISO effects on the anterior free, lateral, and septal segments (Table 2). This regional pattern reflects the left anterior descending coronary artery myocardial distribution [14].
Table 1.
Interaction | ISO effect | RadKO effect | |||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
% total variation |
p-value | % total variation |
p-value | % total variation |
p-value | ||||
Basal infero-lateral |
12.2 | 0.07 | ns | 24.0 | 0.02 | * | 0.5 | 0.76 | ns |
Inferior lateral | 6.3 | 0.16 | ns | 31.0 | 0.008 | ** | 20.4 | 0.03 | * |
Apical lateral | 15.1 | 0.009 | ** | 26.0 | 0.002 | ** | 9.4 | 0.20 | ns |
Basal antero-septal |
26.4 | 0.002 | ** | 21.2 | 0.003 | ** | 7.2 | 0.24 | ns |
Mid antero-septal |
24.1 | 0.03 | * | 12.0 | 0.09 | ns | 19.2 | 0.02 | * |
Apical anterior | 16.4 | 0.02 | * | 26.3 | 0.007 | ** | 2.3 | 0.51 | ns |
ns not significant;
p <0.05;
p <0.01
Table 2.
Interaction | ISO effect | RadKO effect | |||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
% total variation |
p-value | % total variation |
p-value | % total variation |
p-value | ||||
Anterior | 0 | 0.94 | ns | 12.3 | 0.03 | * | 5.0 | 0.29 | ns |
Antero-lateral | 12.7 | 0.03 | * | 25.7 | 0.005 | ** | 2.0 | 0.43 | ns |
Inferior lateral | 1.8 | 0.44 | ns | 10.6 | 0.08 | ns | 5.6 | 0.34 | ns |
Inferior | 0.2 | 0.83 | ns | 2.8 | 0.4 | ns | 0 | 0.97 | ns |
Inferior-septal | 10.8 | 0.10 | ns | 26.7 | 0.02 | * | 0.9 | 0.50 | ns |
Antero-septal | 2.1 | 0.36 | ns | 15.3 | 0.02 | * | 4.6 | 0.34 | ns |
ns not significant
Sarcomere Length Changes Faster in Rad−/− than in WT
The dynamics of the change in sarcomere length (not overall length per se) translate into myocardial function [15]. It is wellestablished that small changes in sarcomeric (and cellular) fractional shortening translate into larger changes in heart wall motion, and a primary effect of Rad−/− is to enhance myocardial Ca2+ homeostasis that in turn drives sarcomere level function. We therefore analyzed sarcomere velocity in WT and Rad−/−. Figure 5a, b plots sarcomere length (SL) along with the rate of change of sarcomere length (Fig. 5c, d) to illustrate sarcomere kinetics. To summarize SL kinetics, we measured the peak velocity of contraction (−dSL/dt; Fig. 5e) and the peak velocity of relaxation (+dSL/dt; Fig. 5f). Rad−/− SL relaxation peak velocity was significantly faster than that for WT (2.5 ± 0.3 and 5.3 ± 0.9 μm/s, p < 0.01, for Rad−/− and WT, respectively), and contractile kinetics trended towards faster values in Rad−/− (3.7 ± 0.5 and 6.1 ± 0.5 μm/s, p = 0.08, for Rad−/− and WT, respectively). These results suggest that in Rad−/− increased Ca2+ homeostasis [3, 4] drives faster sarcomere kinetics.
We previously noted that the Rad−/− basal cellular phenotype approximates WT cardiomyocyte properties following ISO modulation [4]. We therefore evaluated SL kinetics response to acute ISO administration. ISO significantly increased SL contractile (Fig. 5g) and relaxation kinetics (Fig. 5h) in WT but had no effect on Rad−/− cardiomyocytes (Fig. 5i). The ISO-elevated WT kinetics was not different from Rad SL kinetics at baseline.
Rad Levels Decrease in Human Failing Heart
Rad is a member of the RGK subfamily of monomeric G-proteins, and regulation of expression levels is a key defining feature of this protein family [16]. Western blot evaluation of protein levels in human heart shows abundant Rad protein in non-failing control and significantly decreased levels in non-ischemic failing hearts (Fig. 6(a)). Thus, Rad decrease is a clinically relevant response to pathological stimuli. Heart failure patients respond to the 6-min walk test with significantly reduced exercise tolerance [17]. We therefore subjected mice to an exercise tolerance test. During a run to exhaustion test, there was no significant difference between WT and RadKO (Fig. 6(b); WT 20.4 ± 3.8 min, n = 9; RadKO 17.3 ± 3.6 min, n = 5). Taken together, these data are consistent with our working hypothesis that decreased levels of Rad contributes to a compensatory response to preserve heart function.
Discussion
Echocardiography permits non-invasive evaluation of realtime cardiac function, and strain analysis provides a sensitive, early index of alterations of cardiac mechanics in advanced clinical practice [18–20] and in mice [9, 21, 22]. In this study, we show that Rad level decreases in human heart failure, and that Rad deletion in mice results in beneficial heart function. These findings suggest that Rad downregulation in human heart failure may contribute to compensatory beneficial function. Rad deletion shows no age-related decline of myocardial performance and improved global strain. Rad−/− mice have enhanced Ca2+ homeostasis [4, 7] that in turn can drive sarcomere dynamics to ultimately drive cardiac mechanics [15]. We now show evidence that faster sarcomere kinetics in Rad−/− are associated with improved in vivo cardiac performance and mechanics. The in vivo heart mechanics response to ISO parallels that of SL dynamics consistent with a mechanism of action whereby Rad deletion mimics tonic sympathetic activation, yet without deleterious consequences.
The pharmacological stress echocardiography test is a mainstay diagnostic tool for unmasking heart functional deficits in patients with coronary artery disease. Despite its widespread use in patients, there have been few applications in mice. By contrast to echocardiography, acute ISO challenge is widely used at the cellular and ex vivo heart levels to explore myocardial function. Specifically with regard to the effects of Rad, L-type Ca2+ current (ICa,L) demonstrates a ceiling effect with Rad knockout [4] or knockdown [7]. “Ceiling effect” is defined here as baseline measures that are elevated and are not different from WT measures that were maximally stimulated by ISO. Our previous studies showed that in Rad−/− myocyte Ca2+ amplitude and fractional cellular shortening also shows a ceiling effect [4]. In the present study, we now show that SL velocity and LVID;d similarly exhibit the ceiling effect with an ISO stress test. By contrast, the rates of developed pressure and relaxation in the working heart tracks with EF obtained from echo ISO stress test. Depending on parameters measured, four patterns emerge for myocardial responsiveness to the ISO stress test: (1) ceiling effect; (2) WT at baseline <Rad−/− baseline but WT + ISO > Rad−/− + ISO; (3) WT at baseline <Rad−/− baseline but WT + ISO > Rad−/− + ISO, with no Rad−/− + ISO response; and (4) WT ≈ Rad−/−. The first scenario, the ceiling effect fits with a wealth of data biochemically localizing Rad to the LTCC complex where its absence instigates a β AR-like m odulated ICa,L [ 3, 4 , 7 ]. Consequently, βAR modulated ICa,L provides more trigger Ca2+ for Ca2+-induced Ca2+ release logically leading to increased Ca2+ transients, cell shortening, and SL velocities. Correspondence of ceiling effect of these cellular/molecular properties with diastolic chamber dimensions suggests that Ca2+ homeostasis via LTCC contributes to stress-modified LVID;d. Scenario #4 (WT ≈ Rad−/−) is thus far limited to Ca2+ re-uptake and may be attributable to increased SERCa2 in Rad−/− [3]. This is important because it shows that Rad−/− myocardium retains βAR responsiveness which is a contraindication to failing myocardium.
EF and global systolic strain do not follow a ceiling effect for Rad−/−, but a difference between WT and Rad−/− in ISO response is still observed. EF and global systolic strain on first glance show mean values for ISO stimulation whereby WT exceeds Rad−/− function. EF obtained from 2D echocardiography is defined by the ratio of LV inner dimensions at systole and diastole. As noted above, diastolic chamber dimensions show a ceiling effect for ISO stress test for Rad−/−. Therefore, apparent gain in function for WT must come from differential responsiveness to systolic function as suggested by cellular/molecular studies. Perhaps of prime importance is that the relatively minor response of Rad−/− in the ISO stress test is not indicative of myocardial detrimental function, rather is secondary to augmented baseline function.
Strain was not changed by ISO in contrast the EF response. LV inner dimension in diastole is an important contributor to strain. Global systolic strain is a fractional change in stretch; therefore, all else being equal, the smaller the starting dimensions, the greater the absolute value of strain value is recorded. Indeed our data suggests that the plot of strain as a function of LVID;d showed that Rad−/− and Rad−/− + ISO can linearly extrapolate to WT strain. ISO significantly increased global strain independent of LVID;d in WT. The absence of ISO effect on Rad genotype is a consequence of ceiling effect. Apparent lack of change of strain for Rad−/− + ISO relative that of WT + ISO may simply reflect the small LVID;d of Rad−/−. In summary, proper interpretation of strain values must include assessment of LVID;d. This is especially important in rodent models of disease that alter cardiac dimensions with time.
Strain is an early and sensitive indicator of LV global and regional systolic dysfunction, [10, 23, 24] and one goal of this study was to assess whether prior studies overlooked early indicators of loss of function in the Rad−/− heart. The Rad−/− heart exhibits increased fibrosis [2, 3, 8] yet improved EF. This raises two questions contemporaneously: (1) Given that the presence of fibrosis associates with pathology was an early event in heart dysfunction overlooked in earlier studies? and (2) Does the tonic elevated Ca2+ handling in Rad−/− drive pathological function? Circumferential strain is useful here as an early measure that tracks with pathological heart remodeling following trans-aortic constriction in mice. Concurrent with fibrosis, speckle-tracking echocardiography showed declining circumferential strain [25]. Myocardial Ca2+ homeostasis is a focal point for increasing the inotropic response, yet increased Ca2+ can also contribute to pathological remodeling via signaling cascades culminating in altered transcriptional regulation [26, 27]. Forced over-expression of CaV1.2, the LTCC pore-forming channel subunit leads to a long-term, slow, progressive pathological remodeling [28]. CaVβ2 over-expression induces more rapid onset heart failure model [29]. By contrast, Rad deletion elevates LTCC activity with a beneficial stable compensatory state [3]. Therefore, it was important to perform a deeper probe of the question whether early indicators of cardiac dysfunction present in Rad−/− given the incomplete overlapping signaling pathways among Rad−/−, CaV1.2-, and CaVβ2 over-expression. One key distinction is that Rad−/− shows elevated SERCa2 and increased sarcoplasmic reticulum Ca2+ load [3]; each of these findings is counterfactual to canonical heart failure phenotypes [30] but does associate with endurance training [31].
In summary, Rad deletion induces positive under resting conditions. Rad−/− heart dimensions exhibit smaller chamber dimensions but with increased contractility. Clinically inspired pharmacological stress echocardiography testing in mice reveals that ISO-stimulated EF is greater in WT than in Rad−/−, and systolic strain is not influenced by ISO. Although tonic elevated Ca2+ can lead to deleterious myocardial remodeling, preserved systolic strain in Rad−/− supports the idea that reduction in Rad levels, such as observed in heart failure patients, comprises a stable compensatory response to boost resting cardiac output. In addition, Rad−/− hearts have significantly increased fibrosis but retain normal to improved myocardial function. We conclude that targeting Rad reduction is a potential future therapeutic target for treating systolic heart failure and contributes to overcoming the negative mechanical consequences imposed by fibrosis.
Acknowledgments
We thank technical support from F. Weston Dicken (animal colony management) and Wassim Basheer (human sample preparation). We also thank Dr. Steven Leung (U. Kentucky) for critically reading the manuscript.
Sources of Funding National Institutes of Health, National Heart, Lung, and Blood Institute (NIH-NHLBI) HL072936 (DAA & JS), HL074091 (JS); AHA 16GRNT27790094 (JS); NIH R01 HL094414 (RMS); American Heart Association, AHA14POST20460224 (JRM) and NIHF32HL126300 (JRM). NIH T32-HL072743 and National Science Foundation DGE-1247392 (CNW). Research reported in this publication was supported by an Institutional Development Award (IdeA) from the National Institute of General Medical Sciences of the NIH under grant number 8 P20 GM103527-05. The Vevo2100 was generously supported by the Saha Cardiovascular Research Center, University of Kentucky.
Abbreviations
- β-AR
Beta-adrenergic receptor
- EF
Ejection fraction
- ISO
Isoproterenol
- LTCC
L-type calcium channel
- LVEF
Left ventricular ejection fraction
- LVID;d
Left ventricular inner dimension diastolic
- Rad−/−
Genetic global RRAD knockout mouse
- SL
Sarcomere length
Footnotes
Associate Editor Enrique Lara-Pezzi oversaw the review of this article
Compliance with Ethical Standards
Conflict of Interest The authors declare they have no competing interests.
Ethical Approval Animal studies: All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.
Human studies: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
References
- 1.Rockey DC, Bell PD, Hill JA. Fibrosis — A Common Pathway to Organ Injury and Failure. New England Journal of Medicine. 2015;372(12):1138–1149. doi: 10.1056/NEJMra1300575. doi:doi:10.1056/NEJMra1300575. [DOI] [PubMed] [Google Scholar]
- 2.Chang L, Zhang J, Tseng YH, Xie CQ, Ilany J, Bruning JC, et al. Rad GTPase deficiency leads to cardiac hypertrophy. Circulation. 2007;116(25):2976–2983. doi: 10.1161/CIRCULATIONAHA.107.707257. doi:CIRCULATIONAHA.107.707257 [pii]10.1161/CIRCULATIONAHA.107.707257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Manning JR, Withers CN, Levitan B, Smith JD, Andres DA, Satin J. Loss of Rad-GTPase produces a novel adaptive cardiac phenotype resistant to systolic decline with aging. American Journal of Physiology - Heart and Circulatory Physiology. 2015;309(8):H1336–H1345. doi: 10.1152/ajpheart.00389.2015. doi:10.1152/ajpheart.00389.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Manning JR, Yin G, Kaminski CN, Magyar J, Feng HZ, Penn J, et al. Rad GTPase Deletion Increases L-type Calcium Channel Current Leading to Increased Cardiac Contraction. Journal of the American Heart Association. 2013;2(6) doi: 10.1161/JAHA.113.000459. doi:10.1161/jaha.113.000459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hawke TJ, Kanatous SB, Martin CM, Goetsch SC, Garry DJ. Rad is temporally regulated within myogenic progenitor cells during skeletal muscle regeneration. American Journal of Physiology - Cell Physiology. 2006;290(2):C379–C387. doi: 10.1152/ajpcell.00270.2005. doi:10.1152/ajpcell.00270.2005. [DOI] [PubMed] [Google Scholar]
- 6.Finlin BS, Crump SM, Satin J, Andres DA. Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases. PNAS. 2003;100:14469–14474. doi: 10.1073/pnas.2437756100. doi: 10.1073/pnas.2437756100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wang G, Zhu X, Xie W, Han P, Li K, Sun Z, et al. Rad as a novel regulator of excitation-contraction coupling and beta-adrenergic signaling in heart. Circ Res. 2010;106(2):317–327. doi: 10.1161/CIRCRESAHA.109.208272. doi:CIRCRESAHA.109.208272 [pii]10.1161/CIRCRESAHA.109.208272. [DOI] [PubMed] [Google Scholar]
- 8.Zhang J, Chang L, Chen C, Zhang M, Luo Y, Hamblin M, et al. Rad GTPase Inhibits Cardiac Fibrosis through Connective Tissue Growth Factor. [Journal Article] Cardiovasc Res. 2011;91:90–98. doi: 10.1093/cvr/cvr068. doi:10.1093/cvr/cvr068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Shepherd DL, Nichols CE, Croston TL, McLaughlin SL, Petrone AB, Lewis SE, et al. Early detection of cardiac dysfunction in the type 1 diabetic heart using speckle-tracking based strain imaging. Journal of Molecular and Cellular Cardiology. 2016;90:74–83. doi: 10.1016/j.yjmcc.2015.12.001. doi:10.1016/j.yjmcc.2015.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Shah SJ, Aistrup GL, Gupta DK, O'Toole MJ, Nahhas AF, Schuster D, et al. Ultrastructural and cellular basis for the development of abnormal myocardial mechanics during the transition from hypertension to heart failure. Am J Physiol Heart Circ Physiol. 2014;306(1):H88–100. doi: 10.1152/ajpheart.00642.2013. doi:10.1152/ajpheart.00642.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Yada H, Murata M, Shimoda K, Yuasa S, Kawaguchi H, Ieda M, et al. Dominant negative suppression of Rad leads to QT prolongation and causes ventricular arrhythmias via modulation of L-type Ca2+ channels in the heart. Circ Res. 2007;101(1):69–77. doi: 10.1161/CIRCRESAHA.106.146399. doi:CIRCRESAHA.106.146399 [pii]10.1161/CIRCRESAHA.106.146399. [DOI] [PubMed] [Google Scholar]
- 12.Flynn JM, O'Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, et al. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell. 2013;12(5):851–862. doi: 10.1111/acel.12109. doi:10.1111/acel.12109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Davidson SR, Burnett M, Hoffman-Goetz L. Training effects in mice after long-term voluntary exercise. Med Sci Sports Exerc. 2006;38(2):250–255. doi: 10.1249/01.mss.0000183179.86594.4f. doi:10.1249/01.mss.0000183179.86594.4f. [DOI] [PubMed] [Google Scholar]
- 14.Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, et al. Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications Endorsed by the Japanese Society of Echocardiography. European Heart Journal - Cardiovascular Imaging. 2011;12(3):167–205. doi: 10.1093/ejechocard/jer021. doi:10.1093/ejechocard/jer021. [DOI] [PubMed] [Google Scholar]
- 15.Kobirumaki-Shimozawa F, Oyama K, Shimozawa T, Mizuno A, Ohki T, Terui T, et al. Nano-imaging of the beating mouse heart in vivo: Importance of sarcomere dynamics, as opposed to sarcomere length per se, in the regulation of cardiac function. The Journal of General Physiology. 2016;147(1):53–62. doi: 10.1085/jgp.201511484. doi:10.1085/jgp.201511484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Reynet C, Kahn CR. Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science. 1993;262(5138):1441–1444. doi: 10.1126/science.8248782. [DOI] [PubMed] [Google Scholar]
- 17.Guazzi M, Dickstein K, Vicenzi M, Arena R. Six-Minute Walk Test and Cardiopulmonary Exercise Testing in Patients With Chronic Heart Failure: A Comparative Analysis on Clinical and Prognostic Insights. Circulation: Heart Failure. 2009;2(6):549–555. doi: 10.1161/CIRCHEARTFAILURE.109.881326. doi:10.1161/circheartfailure.109.881326. [DOI] [PubMed] [Google Scholar]
- 18.Bijnens B, Claus P, Weidemann F, Strotmann J, Sutherland GR. Investigating Cardiac Function Using Motion and Deformation Analysis in the Setting of Coronary Artery Disease. Circulation. 2007;116(21):2453–2464. doi: 10.1161/CIRCULATIONAHA.106.684357. doi:10.1161/circulationaha.106.684357. [DOI] [PubMed] [Google Scholar]
- 19.Hare JL, Brown JK, Leano R, Jenkins C, Woodward N, Marwick TH. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. American Heart Journal. 2009;158(2):294–301. doi: 10.1016/j.ahj.2009.05.031. doi: http://dx.doi.org/10.1016/j.ahj.2009.05.031. [DOI] [PubMed] [Google Scholar]
- 20.Nishikage T, Nakai H, Mor-Avi V, Lang RM, Salgo IS, Settlemier SH, et al. Quantitative assessment of left ventricular volume and ejection fraction using two-dimensional speckle tracking echocardiography. European Heart Journal - Cardiovascular Imaging. 2009;10(1):82–88. doi: 10.1093/ejechocard/jen166. doi:10.1093/ejechocard/jen166. [DOI] [PubMed] [Google Scholar]
- 21.Bauer M, Cheng S, Jain M, Ngoy S, Theodoropoulos C, Trujillo A, et al. Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ Res. 2011;108(8):908–916. doi: 10.1161/CIRCRESAHA.110.239574. doi:10.1161/CIRCRESAHA.110.239574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yamada S, Arrell DK, Kane GC, Nelson TJ, Perez-Terzic CM, Behfar A, et al. Mechanical Dyssynchrony Precedes QRS Widening in ATP-Sensitive K+ Channel–Deficient Dilated Cardiomyopathy. Journal of the American Heart Association. 2013;2(6) doi: 10.1161/JAHA.113.000410. doi:10.1161/jaha.113.000410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Haggerty CM, Mattingly AC, Kramer SP, Binkley CM, Jing L, Suever JD, et al. Left ventricular mechanical dysfunction in diet-induced obese mice is exacerbated during inotropic stress: a cine DENSE cardiovascular magnetic resonance study. [journal article] Journal of Cardiovascular Magnetic Resonance. 2015;17(1):1–14. doi: 10.1186/s12968-015-0180-7. doi:10.1186/s12968-015-0180-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bhan A, Sirker A, Zhang J, Protti A, Catibog N, Driver W, et al. High Frequency Speckle Tracking Echocardiography in the Assessment of Left Ventricular Function after Murine Myocardial Infarction. American Journal of Physiology - Heart and Circulatory Physiology. 2014 doi: 10.1152/ajpheart.00553.2013. doi:10.1152/ajpheart.00553.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Peng Y, Popović ZB, Sopko N, Drinko J, Zhang Z, Thomas JD, et al. Speckle tracking echocardiography in the assessment of mouse models of cardiac dysfunction. American Journal of Physiology - Heart and Circulatory Physiology. 2009;297(2):H811–H820. doi: 10.1152/ajpheart.00385.2009. doi:10.1152/ajpheart.00385.2009. [DOI] [PubMed] [Google Scholar]
- 26.Maillet M, van Berlo JH, Molkentin JD. Molecular basis of physiological heart growth: fundamental concepts and new players. [10.1038/nrm3495] Nat Rev Mol Cell Biol. 2013;14(1):38–48. doi: 10.1038/nrm3495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.van Berlo JH, Maillet M, Molkentin JD. Signaling effectors underlying pathologic growth and remodeling of the heart. The Journal of Clinical Investigation. 2013;123(1):37–45. doi: 10.1172/JCI62839. doi:10.1172/JCI62839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Muth JN, Yamaguchi H, Mikala G, Grupp IL, Lewis W, Cheng H, et al. Cardiac-specific overexpression of the alpha(1) subunit of the L-type voltage-dependent Ca(2+) channel in transgenic mice. Loss of isoproterenol-induced contraction.PG - 21503-6. J Biol Chem. 1999;274(31):21503–21506. doi: 10.1074/jbc.274.31.21503. [DOI] [PubMed] [Google Scholar]
- 29.Chen X, Nakayama H, Zhang X, Ai X, Harris DM, Tang M, et al. Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy. J Mol Cell Cardiol. 2011;50(50):460–470. doi: 10.1016/j.yjmcc.2010.11.012. doi:S0022-2828(10)00444-X [pii]10.1016/j.yjmcc.2010.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Gorski Przemek A., Ceholski Delaine K., Hajjar Roger J. Altered Myocardial Calcium Cycling and Energetics in Heart Failure—A Rational Approach for Disease Treatment. Cell Metabolism. 2015;21(2):183–194. doi: 10.1016/j.cmet.2015.01.005. doi:http://dx.doi.org/10.1016/j.cmet.2015.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wisløff U, Loennechen JP, Falck G, Beisvag V, Currie S, Smith G, et al. Increased contractility and calcium sensitivity in cardiac myocytes isolated from endurance trained rats. Cardiovascular Research. 2001;50(3):495–508. doi: 10.1016/s0008-6363(01)00210-3. doi:10.1016/s0008-6363(01)00210-3. [DOI] [PubMed] [Google Scholar]